 |
BioWorld-Insight-2002-12-16
Stock Winners and Losers For The Week
Proposed SEC Rule Would Ease Young Firms' Investment Rules
The Securities and Exchange Commission is mulling a rule change that would allow biotechnology firms more flexibility to invest, so they can better advance research and development - and in Washington, the industry push is on for a somewhat more extensive change. (BioWorld Financial Watch)
Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: November 2002
No Abstract